Skip to content

    PROCEPT BioRobotics (PRCT) stock price & financials

    View PRCT earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance48.9% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $58.37M
    $68.24M
    $69.16M
    $79.18M
    $83.33M
    +42.8%
    $76.38M
    +11.9%
    $83.13M
    +20.2%
    $94.50M
    +19.3%
    Strengthening
    Operating Profit
    -$22.43M
    -$19.71M
    -$27.44M
    -$22.19M
    -$23.19M
    -3.4%
    -$31.04M
    -57.5%
    -$32.61M
    -18.8%
    -$27.39M
    -23.4%
    Weakening
    Net Profit
    -$20.97M
    -$18.86M
    -$24.74M
    -$19.58M
    -$21.41M
    -2.1%
    -$29.85M
    -58.3%
    -$31.64M
    -27.9%
    -$26.86M
    -37.2%
    Weakening
    EPS
    $-0.40
    $-0.45
    $-0.35
    $-0.38
    +5.0%
    $-0.56
    -24.4%
    $-0.47
    -34.3%
    Weakening
    Other Income
    Interest
    $1.14M
    $969.0K
    $877.0K
    $895.0K
    $919.0K
    -19.4%
    $895.0K
    -7.6%
    $818.0K
    -6.7%
    $842.0K
    -5.9%
    Weakening
    Depreciation
    Profit before Tax
    -$24.78M
    -$19.44M
    -$31.68M
    -27.8%
    -$26.77M
    -37.7%
    Weakening
    MarginsOPM
    -38.4%
    -28.9%
    -39.7%
    -28.0%
    -27.8%
    +27.6%
    -40.6%
    -40.7%
    -39.2%
    +1.1%
    -29.0%
    -3.4%
    Weakening
    Tax
    0.2%
    -0.7%
    0.1%
    -26.3%
    -0.3%
    +50.0%
    Strengthening
    ReturnsROIC
    3.0%
    2.7%
    3.5%
    2.8%
    3.1%
    +2.1%
    4.3%
    +58.3%
    4.5%
    +27.9%
    3.8%
    +37.2%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$100.13M$304.32M$221.86M$257.22M$333.73M$286.50M$227.91M
    Short-Term Investments
    Total Current Assets$110.26M$326.17M$272.63M$350.57M$481.84M$450.38M$420.29M
    Net PP&E$12.91M$8.32M$32.14M$48.99M$45.65M$47.94M$48.60M
    Goodwill
    Intangibles
    Total Assets$125.97M$337.02M$309.33M$404.72M$534.02M$508.08M$479.35M
    LiabilitiesTotal Current Liabilities$14.53M$16.24M$35.29M$45.93M$53.13M$65.80M$64.20M
    Short-Term Debt$4.55M$0
    Long-Term Debt$44.41M$50.00M$51.21M$51.34M$51.47M$51.62M$51.72M
    Long-Term Leases$4.10M$1.99M$23.98M$26.18M$26.87M$24.65M$23.28M
    Total Liabilities$65.01M$69.93M$112.26M$123.97M$131.80M$142.21M$139.28M
    EquityCommon Stock & APIC$0$0$0$0$0$0$0
    Retained Earnings-$201.67M-$261.52M-$348.68M-$454.57M-$545.99M-$641.56M-$700.06M
    Total Equity-$182.89M$267.09M$197.07M$280.75M$402.22M$365.87M$340.07M
    HighlightsNet Cash / (Debt)$51.17M$254.32M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$48.34M-$57.33M-$80.38M-$108.00M-$99.21M-$48.98M-$74.34M
    Cash from Investing-$233.0K-$592.0K-$2.65M-$25.21M-$4.41M-$9.36M-$10.59M
    Cash from Financing$106.77M$262.12M$3.61M$167.79M$180.13M$11.19M$10.23M
    SummaryCapital Expenditure-$233.0K-$592.0K-$2.65M-$25.21M-$4.41M-$9.36M-$10.59M
    Free Cash Flow-$48.58M-$57.93M-$83.03M-$133.21M-$103.62M-$58.34M-$84.92M
    FCF Margin-629.5%-168.0%-110.7%-97.8%-46.2%-18.9%-25.2%

    Ratios